FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release SyndromeRobert Q. Le, Richard Pazdur, Liang Li et al.|The Oncologist|2018Cited by 880
Velcade®: U.S. FDA Approval for the Treatment of Multiple Myeloma Progressing on Prior TherapyRobert C. Kane, Richard Pazdur, Peter Bross et al.|The Oncologist|2003Cited by 629
FDA Drug Approval Summary: Azacitidine (5-azacytidine, Vidaza™) for Injectable SuspensionEdvardas Kaminskas, Richard Pazdur, Ann T. Farrell et al.|The Oncologist|2005Cited by 488
Sorafenib for the Treatment of Advanced Renal Cell CarcinomaRobert C. Kane, Richard Pazdur, Haleh Saber et al.|Clinical Cancer Research|2006Cited by 466
Approval Summary: Imatinib Mesylate in the Treatment of Metastatic and/or Unresectable Malignant Gastrointestinal Stromal TumorsMartin H. Cohen, Richard Pazdur, Ann T. Farrell et al.|The Oncologist|2009Cited by 429